Antihypertensive Combos Recommended for BTKi-Linked Hypertension
By Elana Gotkine HealthDay Reporter
FRIDAY, Feb. 16, 2024 -- Specific combinations of antihypertensives are recommended for patients with Bruton's tyrosine kinase inhibitor (BTKi)-associated hypertension (HTN), according to a study published online Feb. 5 in Blood Advances.
Laura Samples, M.D., from the Fred Hutchinson Cancer Center in Seattle, and colleagues examined the optimal treatment of BTKi-associated HTN in a study involving randomly selected patients with lymphoid malignancies on a BTKi and antihypertensive drugs with at least three months of follow-up data. Participants were classified as those diagnosed with HTN prior to BTKi initiation (prior HTN; 118 patients) and those diagnosed after BTKi initiation (de novo HTN; 78 patients).
The researchers found that patients with prior HTN who took beta blockers with hydrochlorothiazide and patients diagnosed with de novo HTN who took either an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker with hydrochlorothiazide had significant mean arterial pressure (MAP) reductions (−5.05 and −5.47 mm Hg, respectively). The greatest percentages of normotensive MAPs were also seen in correlation with these regimens.
"Given that increased blood pressure is a 'class effect' of treatment with BTKis, both doctors and patients need to be aware of this risk and patients' blood pressure should be monitored regularly so that treatment can begin immediately when an increase is detected," Samples said in a statement.
The study was funded by AstraZeneca.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Social Determinants of Health Explain Disparities in Treatment-Resistant Hypertension
TUESDAY, May 21, 2024 -- Part of the association between race and incident apparent treatment‐resistant hypertension (aTRH) risk is mediated by social determinants of health, a...
Infertility Treatment Linked to Heart Disease Hospitalization
TUESDAY, May 21, 2024 -- Infertility treatment is associated with an increased risk for hospitalization due to heart disease, according to a study published in the May issue of...
Prehospital Reduction in BP Does Not Improve Stroke Outcomes
MONDAY, May 20, 2024 -- For patients with acute stroke, prehospital reduction in blood pressure does not affect functional outcomes, according to a study published online May 16...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.